$BIIB
BIOGEN INC. Stock $biib

$biib Overview Financials Valuation SEC Filings Company Website

2017 Q3 Form 10-Q Financial Statement

#000087504517000029 Filed on October 24, 2017

Income Statement

Concept	2017 Q3	2016 Q3
Revenue	$3.078B	$2.956B
YoY Change	4.13%	6.4%
Cost Of Revenue	$370.0M	$416.9M
YoY Change	-11.25%	34.48%
Gross Profit	$2.708B	$2.539B
YoY Change	6.65%	2.88%
Gross Profit Margin	87.98%	85.9%
Selling, General & Admin	$433.4M	$462.7M
YoY Change	-6.33%	-3.16%
% of Gross Profit	16.01%	18.22%
Research & Development	$446.4M	$529.0M
YoY Change	-15.61%	1.75%
% of Gross Profit	16.49%	20.84%
Depreciation & Amortization	$177.4M	$180.2M
YoY Change	-1.55%	18.87%
% of Gross Profit	6.55%	7.1%
Operating Expenses	$879.8M	$991.7M
YoY Change	-11.28%	-0.6%
Operating Profit	$1.654B	$1.425B
YoY Change	16.04%	3.9%
Interest Expense	$61.80M	$66.00M
YoY Change	-6.36%	323.08%
% of Operating Profit	3.74%	4.63%
Other Income/Expense, Net	-$44.00M	-$58.10M
YoY Change	-24.27%	277.27%
Pretax Income	$1.610B	$1.367B
YoY Change	17.75%	0.8%
Income Tax	$383.8M	$337.0M
% Of Pretax Income	23.84%	24.65%
Net Earnings	$1.226B	$1.033B
YoY Change	18.7%	6.97%
Net Earnings / Revenue	39.84%	34.94%
Basic Earnings Per Share	$5.80	$4.72
Diluted Earnings Per Share	$5.79	$4.71
COMMON SHARES
Basic Shares Outstanding	211.4M shares	218.9M shares
Diluted Shares Outstanding	211.8M shares	219.4M shares

Balance Sheet

Concept	2017 Q3	2016 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.508B	$4.316B
YoY Change	-18.72%	-26.13%
Cash & Equivalents	$1.548B	$2.085B
Short-Term Investments	$1.960B	$2.231B
Other Short-Term Assets	$967.0M	$993.1M
YoY Change	-2.63%	15.22%
Inventory	$1.007B	$1.010B
Prepaid Expenses
Receivables	$1.568B	$1.468B
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$7.568B	$8.092B
YoY Change	-6.47%	-12.72%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.996B	$2.387B
YoY Change	25.51%	17.71%
Goodwill	$4.128B	$3.420B
YoY Change	20.7%	41.96%
Intangibles	$4.019B	$3.870B
YoY Change	3.86%	-7.45%
Long-Term Investments	$4.362B	$4.324B
YoY Change	0.88%	52.58%
Other Assets	$1.300B	$1.240B
YoY Change	4.9%	38.93%
Total Long-Term Assets	$15.51B	$14.01B
YoY Change	10.65%	22.31%
TOTAL ASSETS
Total Short-Term Assets	$7.568B	$8.092B
Total Long-Term Assets	$15.51B	$14.01B
Total Assets	$23.07B	$22.10B
YoY Change	4.38%	6.64%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$298.7M	$274.0M
YoY Change	9.01%	9.06%
Accrued Expenses	$1.058B	$875.0M
YoY Change	20.91%	5.17%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$573.0M	$5.000M
YoY Change	11360.0%	0.0%
Total Short-Term Liabilities	$3.448B	$2.500B
YoY Change	37.95%	-5.1%
LONG-TERM LIABILITIES
Long-Term Debt	$5.938B	$6.530B
YoY Change	-9.07%	0.02%
Other Long-Term Liabilities	$716.9M	$862.1M
YoY Change	-16.84%	0.08%
Total Long-Term Liabilities	$716.9M	$862.1M
YoY Change	-16.84%	0.08%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.448B	$2.500B
Total Long-Term Liabilities	$716.9M	$862.1M
Total Liabilities	$10.22B	$9.990B
YoY Change	2.34%	-1.69%
SHAREHOLDERS EQUITY
Retained Earnings	$16.11B	$15.03B
YoY Change	7.17%	25.26%
Common Stock	$100.0K	$100.0K
YoY Change	0.0%	-19.35%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$2.977B	$2.612B
YoY Change	13.99%	0.0%
Treasury Stock Shares
Shareholders Equity	$12.86B	$12.12B
YoY Change
Total Liabilities & Shareholders Equity	$23.07B	$22.10B
YoY Change	4.38%	6.64%

Cashflow Statement

Concept	2017 Q3	2016 Q3
OPERATING ACTIVITIES
Net Income	$1.226B	$1.033B
YoY Change	18.7%	6.97%
Depreciation, Depletion And Amortization	$177.4M	$180.2M
YoY Change	-1.55%	18.87%
Cash From Operating Activities	$1.628B	$991.3M
YoY Change	64.26%	10.71%
INVESTING ACTIVITIES
Capital Expenditures	-$279.2M	-$280.7M
YoY Change	-0.53%	22.47%
Acquisitions
YoY Change
Other Investing Activities	-$967.6M	$316.9M
YoY Change	-405.33%	-141.65%
Cash From Investing Activities	-$1.247B	$36.20M
YoY Change	-3544.2%	-103.66%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-19.50M	-305.3M
YoY Change	-93.61%	-110.5%
NET CHANGE
Cash From Operating Activities	1.628B	991.3M
Cash From Investing Activities	-1.247B	36.20M
Cash From Financing Activities	-19.50M	-305.3M
Net Change In Cash	362.0M	722.2M
YoY Change	-49.88%	-74.33%
FREE CASH FLOW
Cash From Operating Activities	$1.628B	$991.3M
Capital Expenditures	-$279.2M	-$280.7M
Free Cash Flow	$1.907B	$1.272B
YoY Change	49.96%	13.11%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	biib	Interest In Subsidiary InterestInSubsidiary	1.00
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	700000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	3200000	USD
	biib	Adjustments To Product Revenue Reserves Relating To Sales In Prior Years AdjustmentsToProductRevenueReservesRelatingToSalesInPriorYears	-2400000	USD
CY2016Q4	biib	Available For Sale Securities Debt Maturities After Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsAmortizedCost	277500000	USD
CY2017Q3	biib	Available For Sale Securities Debt Maturities After Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsAmortizedCost	269300000	USD
CY2016Q4	biib	Available For Sale Securities Debt Maturities After Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsFairValue	276800000	USD
CY2017Q3	biib	Available For Sale Securities Debt Maturities After Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsFairValue	269100000	USD
CY2016	biib	Average Maturity Of Marketable Securities AverageMaturityOfMarketableSecurities	P12M
	biib	Average Maturity Of Marketable Securities AverageMaturityOfMarketableSecurities	P17M
CY2016Q4	biib	Collaborationexpensesaccrual Collaborationexpensesaccrual	130900000	USD
CY2017Q3	biib	Collaborationexpensesaccrual Collaborationexpensesaccrual	180100000	USD
CY2016Q3	biib	Collaborationprofitlosssharing Collaborationprofitlosssharing	4700000	USD
	biib	Collaborationprofitlosssharing Collaborationprofitlosssharing	-900000	USD
CY2017Q3	biib	Collaborationprofitlosssharing Collaborationprofitlosssharing	35200000	USD
	biib	Collaborationprofitlosssharing Collaborationprofitlosssharing	82500000	USD
	biib	Current Provisions To Product Revenue Reserves Relating To Sales In Current Year CurrentProvisionsToProductRevenueReservesRelatingToSalesInCurrentYear	2123200000	USD
CY2016Q4	biib	Duefromanti Cd20therapeuticprograms DuefromantiCD20therapeuticprograms	300600000	USD
CY2017Q3	biib	Duefromanti Cd20therapeuticprograms DuefromantiCD20therapeuticprograms	518000000	USD
CY2016Q3	biib	Effective Income Tax Rate Reconciliation Manufacturing Deduction EffectiveIncomeTaxRateReconciliationManufacturingDeduction	-0.018
	biib	Effective Income Tax Rate Reconciliation Manufacturing Deduction EffectiveIncomeTaxRateReconciliationManufacturingDeduction	-0.017
CY2017Q3	biib	Effective Income Tax Rate Reconciliation Manufacturing Deduction EffectiveIncomeTaxRateReconciliationManufacturingDeduction	-0.020
	biib	Effective Income Tax Rate Reconciliation Manufacturing Deduction EffectiveIncomeTaxRateReconciliationManufacturingDeduction	-0.021
CY2016Q4	biib	Investment In Biotechnology Companies That Are Determined To Be Unconsolidated Variable Interest Entities InvestmentInBiotechnologyCompaniesThatAreDeterminedToBeUnconsolidatedVariableInterestEntities	47400000	USD
CY2016Q4	biib	Inventorynetcurrentandnoncurrent Inventorynetcurrentandnoncurrent	1039400000	USD
CY2017Q3	biib	Inventorynetcurrentandnoncurrent Inventorynetcurrentandnoncurrent	1031200000	USD
CY2017Q3	biib	Investment In Biotechnology Companies That Are Determined To Be Unconsolidated Variable Interest Entities InvestmentInBiotechnologyCompaniesThatAreDeterminedToBeUnconsolidatedVariableInterestEntities	49700000	USD
CY2016Q3	biib	Noncontrollinginterestincreasedecreaseother Noncontrollinginterestincreasedecreaseother	100000	USD
	biib	Noncontrollinginterestincreasedecreaseother Noncontrollinginterestincreasedecreaseother	100000	USD
CY2017Q3	biib	Noncontrollinginterestincreasedecreaseother Noncontrollinginterestincreasedecreaseother	0	USD
	biib	Noncontrollinginterestincreasedecreaseother Noncontrollinginterestincreasedecreaseother	0	USD
	biib	Payments Returns Applied Against Product Revenue Reserves Relating To Current Year PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToCurrentYear	1547300000	USD
	biib	Payments Returns Applied Against Product Revenue Reserves Relating To Prior Year PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToPriorYear	519200000	USD
CY2016Q3	biib	Revenuesfromanti Cd20therapeuticprograms RevenuesfromantiCD20therapeuticprograms	317600000	USD
	biib	Revenuesfromanti Cd20therapeuticprograms RevenuesfromantiCD20therapeuticprograms	996300000	USD
CY2017Q3	biib	Revenuesfromanti Cd20therapeuticprograms RevenuesfromantiCD20therapeuticprograms	406500000	USD
	biib	Revenuesfromanti Cd20therapeuticprograms RevenuesfromantiCD20therapeuticprograms	1144200000	USD
CY2016Q3	biib	Share Based Compensation Expense Included In Costs And Expenses ShareBasedCompensationExpenseIncludedInCostsAndExpenses	50700000	USD
	biib	Share Based Compensation Expense Included In Costs And Expenses ShareBasedCompensationExpenseIncludedInCostsAndExpenses	147700000	USD
CY2017Q3	biib	Share Based Compensation Expense Included In Costs And Expenses ShareBasedCompensationExpenseIncludedInCostsAndExpenses	40600000	USD
	biib	Share Based Compensation Expense Included In Costs And Expenses ShareBasedCompensationExpenseIncludedInCostsAndExpenses	120000000	USD
CY2016Q4	biib	Unrealized Gain Losses On Foreign Currency Derivatives Net Before Tax UnrealizedGainLossesOnForeignCurrencyDerivativesNetBeforeTax	49800000	USD
CY2017Q3	biib	Unrealized Gain Losses On Foreign Currency Derivatives Net Before Tax UnrealizedGainLossesOnForeignCurrencyDerivativesNetBeforeTax	-113000000	USD
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2017
	dei	Document Period End Date DocumentPeriodEndDate	2017-09-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0000875045
CY2017Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	211476936	shares
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	BIOGEN INC.
CY2016Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	279800000	USD
CY2017Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	298700000	USD
CY2016Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1441600000	USD
CY2017Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1567500000	USD
CY2016Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	195800000	USD
CY2017Q3	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	190800000	USD
CY2016Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1439300000	USD
CY2017Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1580600000	USD
CY2015Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-224000000	USD
CY2016Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-300900000	USD
CY2016Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-319900000	USD
CY2017Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-329400000	USD
CY2016Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	0	USD
CY2017Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	59200000	USD
CY2016Q3	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	53900000	USD
	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	158400000	USD
CY2017Q3	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	43100000	USD
	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	127600000	USD
CY2016Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	99700000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	281400000	USD
CY2017Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	108900000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	674900000	USD
CY2016Q4	us-gaap	Assets Assets	22876800000	USD
CY2016Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	5398000000	USD
CY2017Q3	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	5026200000	USD
CY2017Q3	us-gaap	Assets Assets	23073200000	USD
CY2016Q4	us-gaap	Assets Current AssetsCurrent	8732200000	USD
CY2017Q3	us-gaap	Assets Current AssetsCurrent	7568000000	USD
CY2016Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	5406300000	USD
CY2017Q3	us-gaap	Available For Sale Securities AvailableForSaleSecurities	5022200000	USD
CY2016Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	2900000	USD
CY2017Q3	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	4100000	USD
CY2016Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	11200000	USD
CY2017Q3	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	8100000	USD
CY2016Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	5406300000	USD
CY2017Q3	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	5026200000	USD
CY2016Q4	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	2568600000	USD
CY2017Q3	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	1960200000	USD
CY2016Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	2559700000	USD
CY2017Q3	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	2795700000	USD
CY2016Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	2552600000	USD
CY2017Q3	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	2792900000	USD
CY2016Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	2569100000	USD
CY2017Q3	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	1961200000	USD
CY2016Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	2568600000	USD
CY2017Q3	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	1960200000	USD
CY2016Q3	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	1100000	USD
	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	2100000	USD
CY2017Q3	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	300000	USD
	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	2700000	USD
CY2016Q3	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	1100000	USD
	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	2700000	USD
CY2017Q3	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	1200000	USD
	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	4400000	USD
CY2016Q4	us-gaap	Available For Sale Securities Noncurrent AvailableForSaleSecuritiesNoncurrent	2829400000	USD
CY2017Q3	us-gaap	Available For Sale Securities Noncurrent AvailableForSaleSecuritiesNoncurrent	3062000000	USD
CY2016Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	580800000	USD
CY2017Q3	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	611500000	USD
CY2016Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	246800000	USD
CY2017Q3	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	280000000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1308000000	USD
CY2016Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2084800000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2326500000	USD
CY2017Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1548100000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	776100000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-832800000	USD
CY2016Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	2039600000	USD
CY2017Q3	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	1184300000	USD
CY2016Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0005
CY2017Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0005
CY2016Q4	us-gaap	Common Stock Value CommonStockValue	100000	USD
CY2017Q3	us-gaap	Common Stock Value CommonStockValue	100000	USD
CY2016Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1014800000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	2976700000	USD
CY2017Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1235500000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	2827000000	USD
CY2016Q3	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	2600000	USD
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	5700000	USD
CY2017Q3	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	0	USD
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	100000	USD
CY2016Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	1012200000	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	2971000000	USD
CY2017Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	1235500000	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	2826900000	USD
CY2016Q4	us-gaap	Construction Payable Current And Noncurrent ConstructionPayableCurrentAndNoncurrent	134000000	USD
CY2017Q3	us-gaap	Construction Payable Current And Noncurrent ConstructionPayableCurrentAndNoncurrent	157600000	USD
CY2016Q3	us-gaap	Cost Of Goods Sold CostOfGoodsSold	416900000	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	1100200000	USD
CY2017Q3	us-gaap	Cost Of Goods Sold CostOfGoodsSold	370000000	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	1120800000	USD
CY2016Q3	us-gaap	Costs And Expenses CostsAndExpenses	1530500000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	4312600000	USD
CY2017Q3	us-gaap	Costs And Expenses CostsAndExpenses	1424300000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	5088500000	USD
CY2016Q4	us-gaap	Debt Current DebtCurrent	4700000	USD
CY2017Q3	us-gaap	Debt Current DebtCurrent	573200000	USD
CY2016Q4	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	6808400000	USD
CY2017Q3	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	7048300000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-56800000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-39700000	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	93100000	USD
CY2017Q3	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	120700000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	505300000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	992000000	USD
CY2016Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.72
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	13.95
CY2017Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	5.80
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	13.32
CY2016Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	4.71
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	13.92
CY2017Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	5.79
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	13.30
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	54400000	USD
CY2016Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.247
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.256
CY2017Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.238
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.239
CY2016Q3	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.350
CY2017Q3	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.350
CY2016Q3	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.101
	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.094
CY2017Q3	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.114
	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.114
CY2016Q3	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Depreciation And Amortization EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDepreciationAndAmortization	0.012
	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Depreciation And Amortization EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDepreciationAndAmortization	0.011
CY2017Q3	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Depreciation And Amortization EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDepreciationAndAmortization	0.012
	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Depreciation And Amortization EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDepreciationAndAmortization	0.013
CY2016Q3	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0.002
	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0.005
CY2017Q3	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0.006
	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0.007
CY2016Q3	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.005
	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.004
CY2017Q3	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.004
	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.006
CY2016Q3	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.011
	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.010
CY2017Q3	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.007
	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.006
CY2016Q3	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	0.014
	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	0.013
CY2017Q3	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	0.007
	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	0.008
CY2016Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	282900000	USD
CY2017Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	241900000	USD
CY2016Q3	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	3200000	USD
	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	10700000	USD
CY2017Q3	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	2500000	USD
	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	7600000	USD
CY2016Q3	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	14600000	USD
	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	42500000	USD
CY2017Q3	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	10900000	USD
	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	31800000	USD
CY2016Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-5900000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-18800000	USD
CY2017Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-30000000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-61200000	USD
CY2016Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases	0	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases	0	USD
CY2017Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases	0	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases	0	USD
CY2016Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	0	USD
CY2017Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	0	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	6700000	USD
	us-gaap	Fair Value Measurements Changes In Valuation Techniques FairValueMeasurementsChangesInValuationTechniques	0
CY2016Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	3934000000	USD
CY2017Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	4276400000	USD
CY2017Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	421300000	USD
CY2017Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	106800000	USD
CY2017Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	244700000	USD
CY2017Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	256600000	USD
CY2017Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	389600000	USD
CY2017Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	404000000	USD
CY2016Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-4900000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-2600000	USD
CY2017Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	6700000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	8400000	USD
CY2016Q3	us-gaap	Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments	-400000	USD
	us-gaap	Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments	-16600000	USD
CY2017Q3	us-gaap	Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments	1200000	USD
	us-gaap	Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments	5700000	USD
CY2016Q3	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	800000	USD
	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-300000	USD
CY2017Q3	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-4000000	USD
	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-15000000	USD
CY2016Q4	us-gaap	Goodwill Goodwill	3669300000	USD
CY2017Q3	us-gaap	Goodwill Goodwill	4127500000	USD
	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	762400000	USD
CY2017Q3	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	0	USD
	us-gaap	Goodwill Other Increase Decrease GoodwillOtherIncreaseDecrease	9900000	USD
CY2016Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1367200000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	4094800000	USD
CY2017Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1609900000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	3729000000	USD
CY2016Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0	USD
CY2017Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0	USD
CY2016Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	337000000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1047000000	USD
CY2017Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	383800000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	892600000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	238100000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	225800000	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-147400000	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	170500000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-175500000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-504500000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	155100000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	170300000	USD
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-62000000	USD
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	250200000	USD
CY2016Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	7742300000	USD
CY2017Q3	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	8295800000	USD
CY2016Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3808300000	USD
CY2017Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	4019400000	USD
CY2016Q3	us-gaap	Interest Expense InterestExpense	66000000	USD
	us-gaap	Interest Expense InterestExpense	195200000	USD
CY2017Q3	us-gaap	Interest Expense InterestExpense	61800000	USD
	us-gaap	Interest Expense InterestExpense	188800000	USD
CY2016Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	170300000	USD
CY2017Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	175500000	USD
CY2016Q4	us-gaap	Inventory Net InventoryNet	1001600000	USD
CY2017Q3	us-gaap	Inventory Net InventoryNet	1007200000	USD
CY2016Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	37800000	USD
CY2017Q3	us-gaap	Inventory Noncurrent InventoryNoncurrent	24000000	USD
CY2016Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	170400000	USD
CY2017Q3	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	208100000	USD
CY2016Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	698700000	USD
CY2017Q3	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	647600000	USD
CY2016Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	16400000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	43000000	USD
CY2017Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	20600000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	54200000	USD
CY2016Q4	us-gaap	Liabilities Liabilities	10748200000	USD
CY2017Q3	us-gaap	Liabilities Liabilities	10224300000	USD
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	22876800000	USD
CY2017Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	23073200000	USD
CY2016Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3419900000	USD
CY2017Q3	us-gaap	Liabilities Current LiabilitiesCurrent	3448400000	USD
CY2016Q4	us-gaap	Litigation Reserve LitigationReserve	454800000	USD
CY2017Q3	us-gaap	Litigation Reserve LitigationReserve	0	USD
CY2017Q1	us-gaap	Litigation Settlement Amount Awarded To Other Party LitigationSettlementAmountAwardedToOtherParty	1250000000	USD
CY2016	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	454800000	USD
CY2016Q4	us-gaap	Long Term Debt LongTermDebt	6512700000	USD
CY2017Q3	us-gaap	Long Term Debt LongTermDebt	5938300000	USD
CY2015Q4	us-gaap	Minority Interest MinorityInterest	2100000	USD
CY2016Q2	us-gaap	Minority Interest MinorityInterest	-100000	USD
CY2016Q3	us-gaap	Minority Interest MinorityInterest	-2700000	USD
CY2016Q4	us-gaap	Minority Interest MinorityInterest	-11500000	USD
CY2017Q2	us-gaap	Minority Interest MinorityInterest	-11600000	USD
CY2017Q3	us-gaap	Minority Interest MinorityInterest	-11600000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-326100000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1671900000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1903100000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2193600000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	3005300000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	3032700000	USD
CY2016Q3	us-gaap	Net Income Loss NetIncomeLoss	1032900000	USD
	us-gaap	Net Income Loss NetIncomeLoss	3053600000	USD
CY2017Q3	us-gaap	Net Income Loss NetIncomeLoss	1226100000	USD
	us-gaap	Net Income Loss NetIncomeLoss	2836500000	USD
CY2016Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-2700000	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-5800000	USD
CY2017Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-100000	USD
CY2016Q3	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	0	USD
	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	900000	USD
CY2017Q3	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	0	USD
	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	0	USD
CY2016Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-58100000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-169400000	USD
CY2017Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-43600000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-149400000	USD
CY2016Q4	us-gaap	Notes Payable NotesPayable	6499300000	USD
CY2017Q3	us-gaap	Notes Payable NotesPayable	6494700000	USD
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2016Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	1425300000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	4264200000	USD
CY2017Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	1653500000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	3878400000	USD
CY2016Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	685700000	USD
CY2017Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	606100000	USD
CY2016Q4	us-gaap	Other Assets Current OtherAssetsCurrent	1093300000	USD
CY2017Q3	us-gaap	Other Assets Current OtherAssetsCurrent	967000000	USD
CY2016Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1335800000	USD
CY2017Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1300400000	USD
CY2016Q3	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-5400000	USD
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	1600000	USD
CY2017Q3	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	1000000	USD
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	6600000	USD
	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	-78200000	USD
	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	-24800000	USD
CY2016Q3	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	1300000	USD
	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	-17000000	USD
CY2017Q3	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	-35500000	USD
	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	-162300000	USD
CY2016Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-14400000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-62800000	USD
CY2017Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	43900000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	146700000	USD
CY2016Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-18100000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-76900000	USD
CY2017Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	9400000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-9500000	USD
CY2016Q3	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-400000	USD
	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-1300000	USD
CY2017Q3	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	0	USD
	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	500000	USD
CY2016Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	2903500000	USD
CY2017Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	2455200000	USD
CY2016Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	722500000	USD
CY2017Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	716900000	USD
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-45300000	USD
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-126900000	USD
CY2016Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-4400000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-14300000	USD
CY2017Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-5100000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-8200000	USD
CY2016Q3	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	98600000	USD
	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	265500000	USD
CY2017Q3	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	48800000	USD
	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	180400000	USD
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	12800000	USD
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	5100000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	348900000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1365400000	USD
	us-gaap	Payments Of Capital Distribution PaymentsOfCapitalDistribution	0	USD
	us-gaap	Payments Of Capital Distribution PaymentsOfCapitalDistribution	302700000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	12400000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	10700000	USD
	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	5631700000	USD
	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	4093900000	USD
	us-gaap	Payments To Acquire In Process Research And Development PaymentsToAcquireInProcessResearchAndDevelopment	0	USD
	us-gaap	Payments To Acquire In Process Research And Development PaymentsToAcquireInProcessResearchAndDevelopment	120000000	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	110400000	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	910400000	USD
	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	900000000	USD
	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	900000000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	434000000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	636800000	USD
CY2016Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2017Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2016Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2017Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2016Q4	us-gaap	Prepaid Taxes PrepaidTaxes	817000000	USD
CY2017Q3	us-gaap	Prepaid Taxes PrepaidTaxes	714400000	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	37900000	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	10100000	USD
CY2016Q3	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	2362200000	USD
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	5185800000	USD
CY2017Q3	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	888100000	USD
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	4472600000	USD
CY2016Q3	us-gaap	Profit Loss ProfitLoss	1030200000	USD
	us-gaap	Profit Loss ProfitLoss	3047800000	USD
CY2017Q3	us-gaap	Profit Loss ProfitLoss	1226100000	USD
	us-gaap	Profit Loss ProfitLoss	2836400000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2501800000	USD
CY2017Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2995900000	USD
	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	1300000	USD
	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	15300000	USD
	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	2700000	USD
	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	3200000	USD
CY2016Q3	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	529000000	USD
	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	1439400000	USD
CY2017Q3	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	446400000	USD
	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	1666000000	USD
CY2016Q3	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	0	USD
	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	0	USD
CY2017Q3	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	0	USD
	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	120000000	USD
CY2016Q3	us-gaap	Restructuring Charges RestructuringCharges	11600000	USD
	us-gaap	Restructuring Charges RestructuringCharges	21300000	USD
CY2017Q3	us-gaap	Restructuring Charges RestructuringCharges	0	USD
	us-gaap	Restructuring Charges RestructuringCharges	0	USD
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	15071600000	USD
CY2017Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	16107700000	USD
CY2016Q3	us-gaap	Revenues Revenues	2955800000	USD
	us-gaap	Revenues Revenues	8576800000	USD
CY2017Q3	us-gaap	Revenues Revenues	3077800000	USD
	us-gaap	Revenues Revenues	8966900000	USD
CY2016Q3	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	2539600000	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	7315000000	USD
CY2017Q3	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	2622500000	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	7642300000	USD
CY2016Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	462700000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1452400000	USD
CY2017Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	433800000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1363100000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	117800000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	97400000	USD
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	12140100000	USD
CY2017Q3	us-gaap	Stockholders Equity StockholdersEquity	12860500000	USD
CY2016Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	12128600000	USD
CY2017Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	12848900000	USD
	us-gaap	Stockholders Equity Note Spinoff Transaction StockholdersEquityNoteSpinoffTransaction	852800000	USD
	us-gaap	Stockholders Equity Period Increase Decrease StockholdersEquityPeriodIncreaseDecrease	720300000	USD
CY2016Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	231900000	USD
CY2017Q3	us-gaap	Taxes Payable Current TaxesPayableCurrent	121300000	USD
CY2016Q4	us-gaap	Treasury Stock Value TreasuryStockValue	2611700000	USD
CY2017Q3	us-gaap	Treasury Stock Value TreasuryStockValue	2977100000	USD
CY2016Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	605500000	USD
CY2017Q3	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	664600000	USD
CY2016Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	500000	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	400000	shares
CY2017Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	400000	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	300000	shares
CY2016Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	219400000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	219400000	shares
CY2017Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	211800000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	213300000	shares
CY2016Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	218900000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	219000000	shares
CY2017Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	211400000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	213000000	shares
	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The preparation of our condensed consolidated financial statements requires us to make estimates, judgments and assumptions that may affect the reported amounts of assets, liabilities, equity, revenues and expenses and related disclosure of contingent assets and liabilities. On an ongoing basis we evaluate our estimates, judgments and methodologies. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable, the results of which form the basis for making judgments about the carrying values of assets, liabilities and equity and the amount of revenues and expenses. Actual results may differ from these estimates under different assumptions or conditions.</font></div></div>

Files In Submission

Name	View Source	Status
0000875045-17-000029-index-headers.html	Edgar Link	pending
0000875045-17-000029-index.html	Edgar Link	pending
0000875045-17-000029.txt	Edgar Link	pending
0000875045-17-000029-xbrl.zip	Edgar Link	pending
biib-20170930.xml	Edgar Link	completed
biib-20170930.xsd	Edgar Link	pending
biib-20170930_cal.xml	Edgar Link	unprocessable
biib-20170930_def.xml	Edgar Link	unprocessable
biib-20170930_lab.xml	Edgar Link	unprocessable
biib-20170930_pre.xml	Edgar Link	unprocessable
biib-2017930acquirediprd.jpg	Edgar Link	pending
biib-2017930amortization.jpg	Edgar Link	pending
biib-2017930anticd.jpg	Edgar Link	pending
biib-2017930biosimilars.jpg	Edgar Link	pending
biib-2017930collaborationps.jpg	Edgar Link	pending
biib-2017930cos.jpg	Edgar Link	pending
biib-2017930glfvcc.jpg	Edgar Link	pending
biib-2017930highlights.jpg	Edgar Link	pending
biib-2017930incometax.jpg	Edgar Link	pending
biib-2017930interferon.jpg	Edgar Link	pending
biib-2017930oie.jpg	Edgar Link	pending
biib-2017930otherrevenues.jpg	Edgar Link	pending
biib-2017930rd.jpg	Edgar Link	pending
biib-2017930rdpie2016.jpg	Edgar Link	pending
biib-2017930rdpie2017.jpg	Edgar Link	pending
biib-2017930reserves.jpg	Edgar Link	pending
biib-2017930sga.jpg	Edgar Link	pending
biib-2017930spinraza.jpg	Edgar Link	pending
biib-2017930tecfidera.jpg	Edgar Link	pending
biib-2017930tysabri.jpg	Edgar Link	pending
biib-2017930x10q.htm	Edgar Link	pending
biib-2017930xex311.htm	Edgar Link	pending
biib-2017930xex312.htm	Edgar Link	pending
biib-2017930xex321.htm	Edgar Link	pending
biib-2017930zinbryta.jpg	Edgar Link	pending
biogenlogostandarda10.jpg	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BIIB
BIOGEN INC. Stock $biib

2017 Q3 Form 10-Q Financial Statement

#000087504517000029 Filed on October 24, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BIIB BIOGEN INC. Stock $biib

2017 Q3 Form 10-Q Financial Statement

#000087504517000029 Filed on October 24, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BIIB
BIOGEN INC. Stock $biib